FLAM
TEVA icon

First Light Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

First Light Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,897,506
Closed -$15.2M – 79
2021
Q4 		$15.2M Sell
1,897,506
-725,525
-28% -$6.55M 1.09% 30
2021
Q3 		$25.5M Sell
2,623,031
-350,061
-12% -$3.28M 1.68% 25
2021
Q2 		$29.4M Sell
2,973,092
-701,012
-19% -$7.42M 1.77% 25
2021
Q1 		$42.4M Buy
3,674,104
+282,692
+8% +$3.24M 2.81% 15
2020
Q4 		$32.7M Buy
3,391,412
+1,531,387
+82% +$14.7M 2.42% 14
2020
Q3 		$16.8M Sell
1,860,025
-224,078
-11% -$2.37M 1.72% 20
2020
Q2 		$25.7M Buy
2,084,103
+240,857
+13% +$2.72M 2.99% 11
2020
Q1 		$16.6M Buy
1,843,246
+187,075
+11% +$1.92M 2.83% 16
2019
Q4 		$16.2M Buy
1,656,171
+686,941
+71% +$6.13M 2.07% 16
2019
Q3 		$6.67M Sell
969,230
-3,004
-0.3% -$23K 1.01% 29
2019
Q2 		$8.97M Buy
972,234
+659,351
+211% +$7.95M 1.25% 27
2019
Q1 		$4.91M Buy
312,883
+32,276
+12% +$569K 0.64% 39
2018
Q4 		$4.33M Buy
+280,607
New +$5.75M 0.69% 34

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

First Light Asset Management's TEVA Position: Q1 2022 in Review

First Light Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 1,897,506 shares — an estimated $15.2M sold.

First Light Asset Management first reported a position in TEVA in Q4 2018 and held it in 13 quarters. The position peaked at $42.4M in Q1 2021. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • First Light Asset Management reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • First Light Asset Management sold 1,897,506 Teva Pharmaceuticals shares in Q1 2022, an estimated $15.2M.
  • First Light Asset Management first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 13 quarters.
  • First Light Asset Management's Teva Pharmaceuticals position peaked at $42.4M in Q1 2021.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.

Based on First Light Asset Management's 13F filing for Q1 2022, filed 13 May 2022.